Congress Park Capital’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $650K | Hold |
5,060
| – | – | 0.18% | 81 |
|
|
2026
Q1 | $609K | Sell |
5,060
-500
| -9% | -$57.7K | 0.19% | 83 |
|
|
2025
Q4 | $585K | Hold |
5,560
| – | – | 0.17% | 85 |
|
|
2025
Q3 | $467K | Hold |
5,560
| – | – | 0.15% | 85 |
|
|
2025
Q2 | $440K | Sell |
5,560
-21
| -0.4% | -$1.67K | 0.14% | 82 |
|
|
2025
Q1 | $501K | Sell |
5,581
-500
| -8% | -$46.7K | 0.19% | 81 |
|
|
2024
Q4 | $605K | Sell |
6,081
-250
| -4% | -$25.8K | 0.22% | 76 |
|
|
2024
Q3 | $719K | Hold |
6,331
| – | – | 0.27% | 70 |
|
|
2024
Q2 | $784K | Buy |
6,331
+21
| +0.3% | +$2.71K | 0.31% | 62 |
|
|
2024
Q1 | $833K | Sell |
6,310
-250
| -4% | -$30.8K | 0.37% | 58 |
|
|
2023
Q4 | $715K | Sell |
6,560
-900
| -12% | -$93.4K | 0.35% | 62 |
|
|
2023
Q3 | $768K | Hold |
7,460
| – | – | 0.4% | 57 |
|
|
2023
Q2 | $861K | Sell |
7,460
-100
| -1% | -$11.4K | 0.43% | 54 |
|
|
2023
Q1 | $804K | Sell |
7,560
-25
| -0.3% | -$2.7K | 0.42% | 56 |
|
|
2022
Q4 | $842K | Sell |
7,585
-605
| -7% | -$61.8K | 0.49% | 50 |
|
|
2022
Q3 | $705K | Hold |
8,190
| – | – | 0.41% | 56 |
|
|
2022
Q2 | $747K | Sell |
8,190
-580
| -7% | -$51.4K | 0.45% | 57 |
|
|
2022
Q1 | $720K | Buy |
8,770
+1
| +0% | +$79 | 0.36% | 66 |
|
|
2021
Q4 | $672K | Sell |
8,769
-261
| -3% | -$20.8K | 0.33% | 73 |
|
|
2021
Q3 | $678K | Sell |
9,030
-99
| -1% | -$7.53K | 0.35% | 63 |
|
|
2021
Q2 | $710K | Sell |
9,129
-568
| -6% | -$42.2K | 0.36% | 63 |
|
|
2021
Q1 | $713K | Buy |
9,697
+1
| +0% | +$74 | 0.4% | 61 |
|
|
2020
Q4 | $757K | Sell |
9,696
-25
| -0.3% | -$1.91K | 0.45% | 49 |
|
|
2020
Q3 | $769K | Buy |
9,721
+1,338
| +16% | +$105K | 0.48% | 47 |
|
|
2020
Q2 | $619K | Buy |
8,383
+1
| +0% | +$75 | 0.48% | 50 |
|
|
2020
Q1 | $615K | Sell |
8,382
-290
| -3% | -$22.8K | 0.55% | 40 |
|
|
2019
Q4 | $753K | Buy |
8,672
+422
| +5% | +$34.7K | 0.56% | 40 |
|
|
2019
Q3 | $663K | Hold |
8,250
| – | – | 0.56% | 42 |
|
|
2019
Q2 | $641K | Buy |
8,250
+3
| +0% | +$230 | 0.51% | 46 |
|
|
2019
Q1 | $654K | Buy |
8,247
+1
| +0% | +$75 | 0.57% | 46 |
|
|
2018
Q4 | $601K | Sell |
8,246
-523
| -6% | -$36.9K | 0.66% | 39 |
|
|
2018
Q3 | $594K | Buy |
8,769
+1
| +0% | +$64 | 0.53% | 49 |
|
|
2018
Q2 | $508K | Buy |
8,768
+106
| +1% | +$5.98K | 0.49% | 54 |
|
|
2018
Q1 | $450K | Buy |
8,662
+211
| +2% | +$11.4K | 0.46% | 57 |
|
|
2017
Q4 | $454K | Buy |
+8,451
| New | +$469K | 0.46% | 63 |
|
Other funds holding MRK
ECSS
Congress Park Capital's MRK Position: Q2 2026 in Review
Congress Park Capital held its Merck (MRK) position steady in Q2 2026 at 5,060 shares worth $650K. The position accounts for 0.18% of the portfolio, ranked #81.
Congress Park Capital first reported a position in MRK in Q4 2017 and has held it in 35 quarters since. The position peaked at $861K in Q2 2023. 1,810 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Congress Park Capital held 5,060 shares of Merck worth $650K as of Q2 2026.
- Congress Park Capital left its Merck share count unchanged in Q2 2026.
- Merck made up 0.18% of Congress Park Capital's portfolio in Q2 2026, its #81 holding.
- Congress Park Capital first reported a position in Merck in Q4 2017 and has held it in 35 quarters since.
- Congress Park Capital's Merck position peaked at $861K in Q2 2023.
- 1,810 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Congress Park Capital's 13F filing for Q2 2026, filed 14 Jul 2026.